• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Vivera picks up new patent for electronic dose-controlled drug delivery devices

May 25, 2022 By Sean Whooley

Vivera Zicoh drug delivery device
The Zicoh drug delivery device. [Image from Vivera]
Vivera announced today that it received a third U.S. patent for its Zicoh electronic dose-controlled drug delivery device portfolio.

Newport Beach, California–based Vivera’s latest patent from the U.S. Patent and Trademark Office (USPTO) secures Zicoh’s rights as a smart dosing system with automated delivery, measurement, and management for oral format medications, including pills, capsules and tablets.

Vivera said it designed Zicoh to enable real-time communication through the drug supply chain, from manufacturers, distributers and wholesalers to pharmacists, providers, physicians, caregivers and patients. The device can be programmed to dispense the medication dosage type, amount and frequency according to providers’ orders to ensure compliance with prescriptions while implementing controls to help prevent medication misuse and abuse.

Vivera said later versions of the device are set to implement user authentication features like fingerprint authorization and facial recognition to prevent prescription drugs from being diverted. Reminders can be programmed into Zicoh by the pharmacist per a physician’s orders to alert a patient when its time to take their medication.

The company noted that its third patent differs from the previous two as it specifically pertains to dispensing tablets, capsules and pills. The device already has patents as a smart liquid and inhaler delivery device with automation.

Vivera said it plans to have a working prototype for Zicoh in late summer 2022.

“We are proud of the progress we have made on the development of ZICOH’s multiplatform uses and technology,” Vivera CEO and Chair Paul Edalat said in a news release. “The way that Tesla revolutionized the automotive industry, and the way Apple created a category for smart devices, is what Vivera is doing to the prescription dispensing industry. ZICOH will forever change the way that medications are prescribed and dispensed, and Vivera is reaching the milestones to get there in a fraction of the time projected.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured Tagged With: Vivera

IN CASE YOU MISSED IT

  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor
  • Mosanna launches with $80M to support nasal spray for obstructive sleep apnea

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS